# NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
> **ANDA213699** · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2022-10-06
## Drug
- **FDA Application Number:** ANDA213699
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
- **Generic name:** NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM; NAPROXEN
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AJANTA PHARMA LTD
- **Manufacturer:** Ajanta Pharma USA Inc.
- **First approval:** 2022-10-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213699)
---
*AI Analytics · CC0 1.0*